Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Cash from Investing Activities: 2020-2025

Historic Cash from Investing Activities for Foghorn Therapeutics (FHTX) over the last 6 years, with Sep 2025 value amounting to $35.6 million.

  • Foghorn Therapeutics' Cash from Investing Activities rose 158.02% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.1 million, marking a year-over-year increase of 917.68%. This contributed to the annual value of -$29.9 million for FY2024, which is 120.70% down from last year.
  • Latest data reveals that Foghorn Therapeutics reported Cash from Investing Activities of $35.6 million as of Q3 2025, which was up 5.14% from $33.8 million recorded in Q2 2025.
  • In the past 5 years, Foghorn Therapeutics' Cash from Investing Activities registered a high of $77.1 million during Q2 2021, and its lowest value of -$159.4 million during Q1 2022.
  • Over the past 3 years, Foghorn Therapeutics' median Cash from Investing Activities value was $29.5 million (recorded in 2023), while the average stood at $19.4 million.
  • As far as peak fluctuations go, Foghorn Therapeutics' Cash from Investing Activities surged by 3,529.23% in 2021, and later tumbled by 4,788.35% in 2022.
  • Over the past 5 years, Foghorn Therapeutics' Cash from Investing Activities (Quarterly) stood at $9.7 million in 2021, then slumped by 167.27% to -$6.5 million in 2022, then spiked by 674.54% to $37.4 million in 2023, then slumped by 40.37% to $22.3 million in 2024, then soared by 158.02% to $35.6 million in 2025.
  • Its Cash from Investing Activities stands at $35.6 million for Q3 2025, versus $33.8 million for Q2 2025 and $29.4 million for Q1 2025.